| P50 | author | Arnold von Eckardstein | Q41607665 |
| | Argelia Medeiros-domingo | Q42635956 |
| | Thomas Lüscher | Q62560161 |
| P2093 | author name string | Ardan M Saguner | |
| | Corinna Brunckhorst | |
| | Chuanyu Wei | |
| | Firat Duru | |
| | Khooshbu Shah | |
| | Deniz Akdis | |
| | H S Vincent Chen | |
| P2860 | cites work | The aging male hypothalamic-pituitary-gonadal axis: pulsatility and feedback | Q24651107 |
| | Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement | Q26799143 |
| | Testosterone and the cardiovascular system: a comprehensive review of the basic science literature | Q26824556 |
| | In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system | Q27026337 |
| | Testosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanisms | Q28084477 |
| | A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28250468 |
| | Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy | Q28299300 |
| | Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy | Q33161961 |
| | Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q33163807 |
| | Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study | Q33668906 |
| | Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria | Q33764619 |
| | Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity | Q34444510 |
| | Sex hormone levels in patients with sudden cardiac arrest | Q34620130 |
| | Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q35531136 |
| | Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment | Q35735685 |
| | Estrogen and Cardiovascular Disease: Is Timing Everything? | Q35812293 |
| | Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiom | Q35847506 |
| | Sex differences in mechanisms of cardiac excitation-contraction coupling | Q36837006 |
| | Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs | Q37120932 |
| | Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. | Q37259910 |
| | The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. | Q37624877 |
| | Sex differences in cardiomyopathies | Q38182007 |
| | Exercise and sex steroid hormones in skeletal muscle | Q38202396 |
| | Sex-dependent alterations of Ca2+ cycling in human cardiac hypertrophy and heart failure | Q40401079 |
| | Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. | Q41120850 |
| | Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus. | Q41200847 |
| | Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. | Q41892305 |
| | Cardiac effects of anabolic steroids. | Q43013693 |
| | Relationship between sex hormones and idiopathic outflow tract ventricular arrhythmias in adult male patients | Q43258739 |
| | Sex and strain differences in adult mouse cardiac repolarization: importance of androgens | Q45203239 |
| | Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity | Q48251929 |
| | A critical evaluation of simple methods for the estimation of free testosterone in serum | Q49081910 |
| | Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. | Q51677766 |
| | 17β-Estradiol Protects Skeletal Myoblasts From Apoptosis Through p53, Bcl-2, and FoxO Families. | Q51726272 |
| | Arrhythmogenic right ventricular cardiomyopathy: implications of next-generation sequencing in appropriate diagnosis. | Q54114284 |
| | Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia | Q58150495 |
| | Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls | Q62671020 |
| | Arrhythmogenic right ventricular cardiomyopathy: a challenging disease of the intercalated disc | Q85880442 |
| | Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers | Q86589091 |
| | Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population | Q86906780 |
| P433 | issue | 19 | |
| P921 | main subject | biomarker | Q864574 |
| | arrhythmogenic right ventricular cardiomyopathy | Q2555727 |
| P304 | page(s) | 1498-1508 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome | |
| P478 | volume | 38 | |